This monthly feature is supplied by Lab Grown Technologies, a platform connecting the people building cellular agriculture, where companies and inventors can showcase their technologies, see what others are building, and spot opportunities for collaboration. Each month, it surfaces a handful of recent patent filings and breaks down what they cover and why they matter.
Most patents never make headlines. They sit in public databases, dense with claims and diagrams, describing the incremental problems that actually determine whether cultivated meat, fish, and leather reach a plate or a production line. We read them so you don’t have to, pulling out the most compelling patent families: the ones tackling cost, scale, texture, and the stubborn technical bottlenecks between a good idea and a real product.
Here are the patents that caught our attention this month:
A meat producer targets the texture gap
A Japanese meat giant is chasing the texture problem that has held plant-based products back from the center of the plate. NH Foods, the largest meat producer in Japan, has filed a method for making high-moisture plant-based meat with the coarse, tearing fiber structure of beef or pork rather than the soft uniformity most plant proteins default to.
The technical claim centers on a tapered cooling die that narrows as the protein-and-water dough exits the machine, forcing the proteins to align into long directional fibers. Whole cuts remain the hardest category for plant-based meat to crack, and a filing like this from an incumbent animal protein company signals where the competitive pressure on texture is coming from.
One compound in place of three
Hanwha Solutions, the South Korean chemicals group, is applying its materials expertise to one of cultivated meat’s cost problems. Its application (WO2026071587A1) tests whether monoethanolamine alone can drive bovine muscle stem cells to differentiate into muscle tissue, without the insulin, transferrin, and selenium usually bundled alongside it in culture supplements.
In the disclosed experiments, cells treated with the single compound reached 36% differentiation against 14% in the control. Cutting a multi-component supplement down to one qualified ingredient matters at scale, where every raw material has to be sourced, validated, and controlled, and fewer inputs generally means better consistency and lower cost.
Replacing serum with microbes
Tufts University, home to one of the field’s leading cellular agriculture labs, is going after the single most expensive ingredient in cultivated meat: fetal bovine serum. Drawn from cattle blood, serum is costly, inconsistent between batches, and a contamination risk, and it keeps the animal in a supposedly animal-free process.
The Tufts filing (WO2026090612A1) replaces it with lysates, the nutrient-rich contents of microbes like fast-growing Vibrio natriegens, brewer’s yeast, and Lactobacillus strains, broken open and filtered into a growth medium. Two details raise the ceiling further: the bacteria can be engineered to produce the expensive growth factor FGF-2 themselves, and spent culture liquid can be recycled to feed the next microbial batch. It is a credible route to a serum-free medium a fermentation facility could actually produce at volume.
Microcarriers built to dissolve
IamFluidics, a Dutch microparticle engineering company, is targeting a step most cell manufacturing quietly loses yield on: getting cells off the surfaces they grew on. Adherent cells need something to attach to inside a bioreactor, but recovering them from conventional solid microcarriers usually takes enzymatic detachment, sieving, washing, and filtration, each stage shedding cells along the way.
IamFluidics has developed a dissolvable microcarrier with an alginate hydrogel core and a collagen-derived coating that dissolves with standard reagents once the culture is done, releasing a single-cell suspension with no physical separation. The company reports greater than 90% cell recovery in roughly 15 minutes, with mesenchymal stem cell cultures reaching about 1.3 billion cells over 14 days in a rocking bioreactor.
